195 related articles for article (PubMed ID: 10953029)
1. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.
Hata Y; Clermont A; Yamauchi T; Pierce EA; Suzuma I; Kagokawa H; Yoshikawa H; Robinson GS; Ishibashi T; Hashimoto T; Umeda F; Bursell SE; Aiello LP
J Clin Invest; 2000 Aug; 106(4):541-50. PubMed ID: 10953029
[TBL] [Abstract][Full Text] [Related]
2. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?
Van Geest RJ; Klaassen I; Vogels IM; Van Noorden CJ; Schlingemann RO
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1857-65. PubMed ID: 19959647
[TBL] [Abstract][Full Text] [Related]
3. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.
Zhao B; Smith G; Cai J; Ma A; Boulton M
Br J Ophthalmol; 2007 Apr; 91(4):538-45. PubMed ID: 16943230
[TBL] [Abstract][Full Text] [Related]
5. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
6. Effect of high glucose concentrations on prostacyclin-stimulating factor mRNA expression in cultured aortic smooth muscle cells.
Ono Y; Umeda F; Kunisaki M; Sekiguchi N; Hashimoto T; Nawata H
Diabetologia; 1998 Feb; 41(2):134-40. PubMed ID: 9498645
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery.
Sekiguchi N; Umeda F; Masakado M; Ono Y; Hashimoto T; Nawata H
Diabetes; 1997 Oct; 46(10):1627-32. PubMed ID: 9313760
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu M; Kuroki M; Amano S; Tolentino M; Keough K; Kim I; Bucala R; Adamis AP
J Clin Invest; 1998 Mar; 101(6):1219-24. PubMed ID: 9502762
[TBL] [Abstract][Full Text] [Related]
9. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina.
Kuiper EJ; Hughes JM; Van Geest RJ; Vogels IM; Goldschmeding R; Van Noorden CJ; Schlingemann RO; Klaassen I
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4267-76. PubMed ID: 17724216
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy.
Umeda F; Ono Y; Masakado M; Sekiguchi N; Yamauchi T; Hashimoto T; Nawata H
Diabetes; 1996 Jul; 45 Suppl 3():S111-3. PubMed ID: 8674874
[TBL] [Abstract][Full Text] [Related]
11. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension.
Suzuma I; Hata Y; Clermont A; Pokras F; Rook SL; Suzuma K; Feener EP; Aiello LP
Diabetes; 2001 Feb; 50(2):444-54. PubMed ID: 11272159
[TBL] [Abstract][Full Text] [Related]
12. Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).
Sueishi K; Hata Y; Murata T; Nakagawa K; Ishibashi T; Inomata H
Pol J Pharmacol; 1996; 48(3):307-16. PubMed ID: 9112668
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic regulation of vascular endothelial growth factor in retinal cells.
Aiello LP; Northrup JM; Keyt BA; Takagi H; Iwamoto MA
Arch Ophthalmol; 1995 Dec; 113(12):1538-44. PubMed ID: 7487623
[TBL] [Abstract][Full Text] [Related]
15. Captopril inhibits glucose accumulation in retinal cells in diabetes.
Zhang JZ; Gao L; Widness M; Xi X; Kern TS
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4001-5. PubMed ID: 12939321
[TBL] [Abstract][Full Text] [Related]
16. Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathy.
Ma J; Li C; Shao C; Gao G; Yang X
Mol Vis; 2012; 18():330-6. PubMed ID: 22355244
[TBL] [Abstract][Full Text] [Related]
17. Deletion of ocular transforming growth factor β signaling mimics essential characteristics of diabetic retinopathy.
Braunger BM; Leimbeck SV; Schlecht A; Volz C; Jägle H; Tamm ER
Am J Pathol; 2015 Jun; 185(6):1749-68. PubMed ID: 25857227
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases.
Maines LW; French KJ; Wolpert EB; Antonetti DA; Smith CD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5022-31. PubMed ID: 17065523
[TBL] [Abstract][Full Text] [Related]
19. Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells.
Pascal MM; Forrester JV; Knott RM
Curr Eye Res; 1999 Aug; 19(2):162-70. PubMed ID: 10420186
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes.
Maile LA; Gollahon K; Wai C; Byfield G; Hartnett ME; Clemmons D
Diabetologia; 2012 Mar; 55(3):835-44. PubMed ID: 22193512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
